These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1371571)

  • 41. Antiarrhythmic efficacy of solitary beta-adrenergic blockade for patients with sustained ventricular tachyarrhythmias.
    Brodsky MA; Allen BJ; Luckett CR; Capparelli EV; Wolff LJ; Henry WL
    Am Heart J; 1989 Aug; 118(2):272-80. PubMed ID: 2568745
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical applications of antiarrhythmic drugs.
    Lavenne F; de Jonghe D
    Acta Cardiol Suppl; 1980; (25):27-42. PubMed ID: 6155012
    [No Abstract]   [Full Text] [Related]  

  • 43. Spontaneous variability in ventricular ectopic activity during chronic antiarrhythmic therapy.
    Anderson JL; Anastasiou-Nana MI; Menlove RL; Moreno FL; Nanas JN; Barker AH
    Circulation; 1990 Sep; 82(3):830-40. PubMed ID: 1697514
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Use of a combination of class III and class Ic antiarrhythmic agents in patients with electrical storm.
    Fuchs T; Groysman R; Meilichov I
    Pharmacotherapy; 2008 Jan; 28(1):14-9. PubMed ID: 18154469
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Electrophysiologic assessment of antiarrhythmic drug efficacy for ventricular tachyarrhythmias associated with dilated cardiomyopathy.
    Rae AP; Spielman SR; Kutalek SP; Kay HR; Horowitz LN
    Am J Cardiol; 1987 Feb; 59(4):291-5. PubMed ID: 3544793
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A comparison of electrophysiologic testing with Holter monitoring to predict antiarrhythmic-drug efficacy for ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators.
    Mason JW
    N Engl J Med; 1993 Aug; 329(7):445-51. PubMed ID: 8332149
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characteristics, prognosis and treatment of the ventricular arrhythmias of right ventricular dysplasia.
    Leclercq JF; Coumel P
    Eur Heart J; 1989 Sep; 10 Suppl D():61-7. PubMed ID: 2572422
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Spectrum of effects of beta receptor blockade in cardiac arrhythmias].
    Lüderitz B
    Z Kardiol; 1986; 75 Suppl 5():41-6. PubMed ID: 2435070
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Value of experimental and clinical methods on the effectiveness and side effect profile of anti-arrhythmia agents].
    Kuck KH
    Z Kardiol; 1992; 81 Suppl 4():151-5. PubMed ID: 1283932
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Discordance between ambulatory monitoring and programmed stimulation in assessing efficacy of class IA antiarrhythmic agents in patients with ventricular tachycardia.
    Kim SG; Seiden SW; Matos JA; Waspe LE; Fisher JD
    J Am Coll Cardiol; 1985 Sep; 6(3):539-44. PubMed ID: 2411776
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Spontaneous variability of ventricular extrasystoles: criteria for validating anti-arrhythmia therapy in relation to the length of the control interval].
    Schmidt G; Goedel-Meinen L; Ulm K; Jahns G; Barthel P; Stief P; Schaudig UH; Klein G; Baedeker W; Blömer H
    Z Kardiol; 1987 May; 76(5):292-5. PubMed ID: 2441534
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Value of Holter monitoring in predicting long-term efficacy and inefficacy of amiodarone used alone and in combination with class 1A antiarrhythmic agents in patients with ventricular tachycardia.
    Kim SG; Felder SD; Figura I; Johnston DR; Waspe LE; Fisher JD
    J Am Coll Cardiol; 1987 Jan; 9(1):169-74. PubMed ID: 3794093
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Days required for 75% suppression of ventricular premature contractions by antiarrhythmic agents obtained from continuous in-hospital ECG monitoring.
    Fujito T; Takayanagi K; Shimizu M; Inoue T; Hayashi T; Sakai Y; Morooka S; Takabatake Y
    Jpn Heart J; 1994 Mar; 35(2):125-40. PubMed ID: 7517462
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Continuous ambulatory electrocardiographic recordings using the Holter system in the late phase of hospitalization for recent myocardial infarct. Value and limitations studied in a series of 100 patients].
    Marco J; Baradat G; Constans R; Alibelli MJ; Berthoumieu H; Dardenne P
    Arch Mal Coeur Vaiss; 1979 Apr; 72(4):376-84. PubMed ID: 38762
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Heart rate variability and baroreflex sensitivity in idiopathic dilated cardiomyopathy.
    Hoffmann J; Grimm W; Menz V; Müller HH; Maisch B
    Heart; 2000 May; 83(5):531-8. PubMed ID: 10768902
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Risk stratification and clinical outcome of minimally symptomatic and asymptomatic patients with nonsustained ventricular tachycardia and coronary disease: a prospective single-center study.
    Giorgberidze I; Saksena S; Krol RB; Munsif AN; Kolettis T; Mathew P; Varanasi S; Prakash A; Delfaut P; Lewis CB
    Am J Cardiol; 1997 Sep; 80(5B):3F-9F. PubMed ID: 9291444
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Arrhythmias in hypertrophic cardiomyopathy. Significance and therapeutic consequences].
    McKenna WJ; Kleinebenne A
    Herz; 1985 Apr; 10(2):91-101. PubMed ID: 2580767
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy of carvedilol on complex ventricular arrhythmias in dilated cardiomyopathy: double-blind, randomized, placebo-controlled study.
    Cice G; Tagliamonte E; Ferrara L; Iacono A
    Eur Heart J; 2000 Aug; 21(15):1259-64. PubMed ID: 10924316
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Risk stratification for arrhythmic events in patients with nonischemic dilated cardiomyopathy and nonsustained ventricular tachycardia: role of programmed ventricular stimulation and the signal-averaged electrocardiogram.
    Turitto G; Ahuja RK; Caref EB; el-Sherif N
    J Am Coll Cardiol; 1994 Nov; 24(6):1523-8. PubMed ID: 7930285
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Effect of barucainide on left ventricular ejection fraction in patients with ventricular cardiac arrhythmias].
    Scheininger M; Dziersk J; Kullak W; Kors A; Köhler JA; Theisen K
    Z Kardiol; 1991 Oct; 80(10):630-6. PubMed ID: 1722935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.